Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00034
|
|||||
| Drug Name |
Creatine ALS-08
|
|||||
| Synonyms |
AL-02 (ALS), Avicena; AL-08 (ALS), Avicena; ALS-02; ALS-05; ALS-08; Creatine; Creatine (ALS), Avicena; Creatine (Huntington's disease), Avicena; Creatine (Parkinson's disease), Avicena; Creatine (amyotrophic lateral sclerosis), Avicena; HD-02; PD-01, Avicena; PD-02; PD-04; PD-06
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Motor neurone disease [ICD11: 8B60] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C4H9N3O2
|
|||||
| Canonical SMILES |
CN(CC(=O)O)C(=N)N
|
|||||
| InChI |
InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)
|
|||||
| InChIKey |
CVSVTCORWBXHQV-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 57-00-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 131.13 | Topological Polar Surface Area | 90.4 | ||
| Heavy Atom Count | 9 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
-1.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
102851574
, 103187076
, 104295252
, 10527747
, 117475574
, 117475575
, 125292581
, 125326843
, 125353363
, 126522989
, 126677726
, 127265156
, 127265157
, 127265158
, 127265159
, 127265160
, 127265161
, 127684899
, 131999723
, 134970539
, 136961253
, 137003471
, 15170675
, 24438948
, 24857517
, 24892273
, 3139605
, 3594
, 46504868
, 4947662
, 50800367
, 56311485
, 56311510
, 56312867
, 56365626
, 57320315
, 57410916
, 74369
, 7886773
, 81065541
, 8137931
, 8143593
, 8150697
, 831847
, 85164924
, 855190
, 87457515
, 87565524
, 88828666
, 93620616
|
|||||
| ChEBI ID |
ChEBI:16919
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | CRTR | Transporter Info | Creatine transporter 1 | Substrate | [2] | |
| MCT12 | Transporter Info | Monocarboxylate transporter 12 | Substrate | [3] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00098956) Effects of Creatine Supplementation on Muscle Mass and Function Among Older Women Subjected to Resistance Training | |||||
| 2 | Astrocytic -aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain. 2018 Feb;113:1-7. | |||||
| 3 | Mutation in the Monocarboxylate Transporter 12 Gene Affects Guanidinoacetate Excretion but Does Not Cause Glucosuria. J Am Soc Nephrol. 2016 May;27(5):1426-36. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.